Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business services solutions for ambulatory care providers through its PrimeSUITE® platform, will release its financial results for the three months and six months ended Dec. 31, 2012, after the securities markets close on Tuesday, Feb. 12, 2013.
Greenway senior executives will review operating and financial highlights during a live teleconference for investors scheduled for 5 p.m. Eastern time that day. Persons interested in participating in the call should dial (888) 679-8034 or (617) 213-4847 for international calls. The participant passcode is 98566108.
The investor conference call can also be accessed through the Investors section of Greenway’s website, www.greenwaymedical.com/investors. A replay of the teleconference will be available at that location shortly after the call, through March 15.
About Greenway and PrimeSUITEGreenway Medical Technologies, Inc. (NYSE: GWAY) delivers smarter solutions for smarter healthcare ™. PrimeSUITE ® — Greenway’s certified and fully integrated electronic health record, practice management and interoperability solution — helps improve care coordination, quality and cost-efficiency as part of a smarter, sustainable healthcare system. Thousands of providers across more than 30 specialties and sub-specialties use cloud-based, remote-hosted or on-premise Greenway ® solutions in healthcare enterprises, physician practices and ambulatory clinics nationwide. For details, see greenwaymedical.com , Twitter, Facebook or YouTube . Greenway, the Greenway logo and PrimeSUITE are registered trademarks and the phrase “smarter solutions for smarter healthcare” is a trademark of Greenway Medical Technologies, Inc. Other product or company names are the property of their respective owners.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV